Advanced search
1 file | 341.99 KB

Tumor necrosis factor-alpha augmented tumor response in B16BL6 melanoma-bearing mice treated with stealth liposomal doxorubicin (DOXIL (R)) correlates with altered DOXIL (R) pharmacokinetics

(2004) INTERNATIONAL JOURNAL OF CANCER. 109(3). p.442-448
Author
Organization

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 341.99 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Brouckaert, Peter, N TAKAHASHI, ST VAN TIEL, Jeroen Hostens, AMM EGGERMONT, ALB SEYNHAEVE, Walter Fiers, and TLM TEN HAGEN. 2004. “Tumor Necrosis Factor-alpha Augmented Tumor Response in B16BL6 Melanoma-bearing Mice Treated with Stealth Liposomal Doxorubicin (DOXIL (R)) Correlates with Altered DOXIL (R) Pharmacokinetics.” International Journal of Cancer 109 (3): 442–448.
APA
Brouckaert, P., TAKAHASHI, N., VAN TIEL, S., Hostens, J., EGGERMONT, A., SEYNHAEVE, A., Fiers, W., et al. (2004). Tumor necrosis factor-alpha augmented tumor response in B16BL6 melanoma-bearing mice treated with stealth liposomal doxorubicin (DOXIL (R)) correlates with altered DOXIL (R) pharmacokinetics. INTERNATIONAL JOURNAL OF CANCER, 109(3), 442–448.
Vancouver
1.
Brouckaert P, TAKAHASHI N, VAN TIEL S, Hostens J, EGGERMONT A, SEYNHAEVE A, et al. Tumor necrosis factor-alpha augmented tumor response in B16BL6 melanoma-bearing mice treated with stealth liposomal doxorubicin (DOXIL (R)) correlates with altered DOXIL (R) pharmacokinetics. INTERNATIONAL JOURNAL OF CANCER. 2004;109(3):442–8.
MLA
Brouckaert, Peter, N TAKAHASHI, ST VAN TIEL, et al. “Tumor Necrosis Factor-alpha Augmented Tumor Response in B16BL6 Melanoma-bearing Mice Treated with Stealth Liposomal Doxorubicin (DOXIL (R)) Correlates with Altered DOXIL (R) Pharmacokinetics.” INTERNATIONAL JOURNAL OF CANCER 109.3 (2004): 442–448. Print.
@article{210480,
  author       = {Brouckaert, Peter and TAKAHASHI, N and VAN TIEL, ST and Hostens, Jeroen and EGGERMONT, AMM and SEYNHAEVE, ALB and Fiers, Walter and TEN HAGEN, TLM},
  issn         = {0020-7136},
  journal      = {INTERNATIONAL JOURNAL OF CANCER},
  language     = {eng},
  number       = {3},
  pages        = {442--448},
  title        = {Tumor necrosis factor-alpha augmented tumor response in B16BL6 melanoma-bearing mice treated with stealth liposomal doxorubicin (DOXIL (R)) correlates with altered DOXIL (R) pharmacokinetics},
  url          = {http://dx.doi.org/10.1002/ijc.11703},
  volume       = {109},
  year         = {2004},
}

Altmetric
View in Altmetric
Web of Science
Times cited: